Nicotine self-administration in animals and humans: Similarities and differences

Psychopharmacology

Volumn 130, Issue 1, 1997, Pages 28-40

  Rose, Jed E ^a,b   Corrigall, William A ^c,d  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dopamine; Nicotine; Reinforcement; Self administration

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BEMESETRON; COCAINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; HALOPERIDOL; MECAMYLAMINE; NALOXONE; NALTREXONE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; ONDANSETRON; SPIPERONE; TROPISETRON;

ANIMAL MODEL; BEHAVIOR; CIGARETTE SMOKING; DRUG SELF ADMINISTRATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MESOLIMBIC DOPAMINERGIC SYSTEM; METHODOLOGY; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; SMOKING CESSATION; SPECIES DIFFERENCE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NICOTINE; SELF ADMINISTRATION;

EID: 0031030483     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050209     Document Type: Review

References (95)

1. Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR (1989) Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet: 7-10
2. Behm FM, Rose JE (1994) Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low-tar cigarettes. Exp Clin Psychopharmacol 2:143-153
3. Behm F, Levin ED, Lee YK, Rose JE (1990) Low-nicotine smoke aerosol reduces desire for cigarettes. J Subst Abuse 2:237-247
4. Benowitz NL, Jacob P III (1990) Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther 254:1000-1005
5. Benowitz NL, Porchet H, Jacob P III (1990) Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology. Oxford University Press, Oxford, pp 112-157
6. Benwell MEM, Balfour DJK (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
7. Benwell MEM, Balfour DJK, Lucchi HM (1993) Influence of letrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology 112: 467-474
8. Benwell MEM, Balfour DJK, Birrell CE (1995) Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 114:454-460
9. Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995) Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 50: 91-96
10. Calabresi P, Lacey MG, North RA (1989) Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98:135-140
11. Clarke P, Fibiger H (1987) Apparent absence of nicotine-induced conditioned place preference in rats. Psychopharmacology 92: 84-88
12. Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358
13. Clarke PBS, Fu DS, Jakubovic A, Fibiger HC (1988) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701-708
14. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR (1984) Prediction of abuse liability of drugs using i.v. self-administration by rats. Psychopharmacology 82:6-13
15. Corrigall WA (1992) A rodent model for nicotine self-administration. In: Boulton A, Baker G, Wu PH (eds) Animal models of drug addiction. Humana Press, Clifton, N.J., pp 315-344
16. Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited access schedule. Psychopharmacology 99:473-478
17. 2 dopamine system through the ventral tegmental area. Pharmacol Biochem Behav 39: 799-802
18. Corrigall WA, Coen KM (1991b) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170
19. Corrigall WA, Coen KM (1991c) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104: 171-176
20. 3 antagonists ICS 205-930 and MDL 72222. Pharmacol Biochem Behav 49:67-71
21. Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS (1992) The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285-289
22. Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
23. Dai S, Corrigall WA, Coen K, Kalant H (1989) Heroin self-administration by rats: influence of dose and physical dependence. Pharmacol Biochem Behav 32:1009-1015
24. Dawe S, Gerada C, Russell MAH, Gray JA (1995) Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology 117:115
25. Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology 122:390-394
26. Fagerström KO (1988) Efficacy of nicotine chewing gum: a review. In: Pomerleau OF, Pomerleau CS (eds) Nicotine replacement: a critical evaluation. A. R. Liss, New York, pp 109-128
27. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MAH (1992) Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology 106:421-127
28. Frost C, Fullerton FM, Stephen AM, Stone R, Nicolaidesbouman A, Densem J, Wald NJ, Semmence A (1995) The tar reduction study: randomized trial of the effect of cigarette tar yield reduction on compensatory smoking. Thorax 50:1038-1043
29. Fudala P, Teoh K, Iwamoto E (1985) Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav 22:237-241
30. Ginzel KH, Eldred E (1977) Rellex depression of somatic motor activity from heart, lungs and carotid sinus. In: Paintal AS, Gill-Kumar P (eds) Krogh Centenary Symposium on Respiratory Adaptation. Capillary Exchange and Reflex Mechanisms. Vallabhbai Patel Chest Institute, University of Delhi, Delhi, pp 358-395
31. Glowa JR, Wojnicki FHE (1996) Effects of dopamine antagonists on cocaine and food-maintained responding in rhesus monkeys. College on Problems of Drug Dependence, Puerto Rico
32. Goldberg SR, Henningfield JE (1996a) A parametric study of intravenous nicotine self-administration by humans and squirrel monkeys. College on Problems of Drus Dependence, Puerto Rico
33. Goldberg SR, Henningfield JE (1996b) A parametric study of intravenous nicotine self-administration by humans and squirrel monkeys. College on Problems of Drug Dependence, Puerto Rico
34. Goldberg SR, Spealman RD, Goldberg DM (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214:573-575
35. Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983) Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 19:1011-1020
36. Gorelick DA, Rose JE, Jarvik ME (1989) Effect of naloxone on cigarette smoking. J Subst Abuse 1:153-159
37. Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol. 1. JAI Press, Greenwich, Conn., pp 1-90
38. Hanson HM, Ivester CA, Morton BR (1979) Nicotine self-administration in rats. In: Krasnegor NA (ed) Cigarette smoking as a dependence process. NIDA Research Monograph 23, USD-HEW, Rockville, Md.
39. Hasenfratz M, Baldinger B, Battig K (1993) Nicotine or tar titration in cigarette smoking behavior? Psychopharmacology 112: 253-258
40. Henningfield J, Miyasato K, Jasinski D (1983) Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav 19:887-890
41. Hughes JR, Glaser M (1993) Transdermal nicotine for smoking cessation. J Health Behav Educ Promot 17:25-31
42. Jarvik ME, Henningfield JE (1988) Pharmacological treatment of tobacco dependence. Pharmacol Biochem Behav 30:279-294
43. Jarvik ME, Glick SD, Nakamura RK (1970) Inhibition of cigarette smokins by orally administered nicotine. Clin Pharmacol Ther 11:574-576
44. Jarvik ME, Caskey NH, Wirshing WC (1995) Dopaminergic modulation of cigarette smoking. Society for Research on Nicotine and Tobacco
45. Johanson CE, Schuster CR (1981) Animal models of drug self-administration. In: Mello NK (ed) Advances in substance abuse, vol. 2. JAI Press, Greenwich, Conn., pp 219-297
46. Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541-1545
47. Kozlowski LT, Herman CP (1984) The Interaction of psychosocial and biological determinants of tobacco use: more on the boundary model. J App Soc Psychol 14:244-256
48. Lee L-Y, Gerhardstein DC, Wang AL, Burki NK (1993) Nicotine is responsible for the airway irritation evoked by cigarette smoke inhalation in men. J Appl Physiol 75:1955-1961
49. Levin ED, Wilson W, McEvoy JP (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology (in press)
50. Lucchesi BR, Schuster CR, Emley GS (1967) The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid. Clin Pharmacol Ther 8:789-796
51. Martin BR, Onaivi ES, Martin TJ (1989) What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem Pharmacol 38:3391-3397
52. McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995) Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119:124-126
53. McMorrow MJ, Foxx RM (1983) Nicotine's role in smoking: an analysis of nicotine regulation. Psych Bull 93:302-327
54. Mifsud JC, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367
55. Museo E, Wise RA (1990) Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacol Biochem Behav 37:735-737
56. Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89:261-264
57. Nisell M, Nomikos GG, T.H. S (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16: 36-44
58. 2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology 104: 343-350
59. Palmer RF, Berens A (1983) Double-blind study of the effect of naloxone on the pleasure of smoking. Fed Proc 42:654
60. Palmer KJ, Buckley MM, Faulds D (1992) Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 44:498-529
61. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE (1992a) Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 52:627-634
62. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE (1992b) Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clin Pharmacol Ther 52:627-634
63. Pomerleau OF, Fertig JF, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61-67
64. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 91:391-393
65. Pomerleau OF, Flessland KA, Pomerleau CS, Hariharan M (1992) Controlled dosing of nicotine via and intranasal aerosol delivery device (INADD). Psychopharmacology 108:519-526
66. 3H]dopamine release from striatal synaptosomes: pharmacological characterization. J Neurochem 50:1123-1130
67. Reavill C, Stolerman IP (1990) Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99:273-278
68. Risner ME, Goldberg SR (1983) A Comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drus infusion. J Pharmacol Exp Ther 224:319-326
69. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
70. Rose JE (1988) The role of upper airway stimulation in smoking. In: Pomerleau OF, Pomerleau CS (eds) Nicotine replacement: a critical evaluation. A. R. Liss, New York, pp 95-106
71. Rose JE, Behm FM (1995) There is more to smokine than the CNS effects of nicotine. In: Clarke PBS, Quik M, Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems II. Birkhäuser Verlag, Basel, pp 9-16
72. Rose JE, Levin ED (1991a) Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacol Biochem Behav 41:219-226
73. Rose JE, Levin ED (1991b) Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. In: West R, Grunberg NE (eds) British Journal of Addiction. Carfax, London, pp 605-610
74. Rose JE, Sampson A, Levin ED, Henningfield JE (1988) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933-938
75. Rose JE, Levin ED, Behm FM, Adivi C, Schur C (1990) Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 47:323-330
76. Rose JE, Behm FM, Levin ED (1993) The role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacol Biochem Behav 44:891-900
77. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Lane JD, Ripka GV (1994a) Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. Exp Clin Psychopharmacol 2:1-17
78. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994b) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56:86-99
79. Rose JE, Westman EC, Behm FM (1996) Nicotine/mecamylamine combination treatment for smoking cessation. Drug Dev Res (in press)
80. 3H]-dopamine release by nicotine in rat nucleus accumbens. J Neurochem 49:1449-1454
81. Russell MAH (1987) Nicotine intake and its regulation by smokers. In: Martin WR, Van Loon GR, Iwamoto ET, Davis KD (eds) Tobacco smoking and nicotine: a neurobiological approach. Plenum Press, New York, pp 25-50
82. Russell MAH (1990) Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford University Press, New York, pp 374-427
83. Sannerud CA, Prada J, Goldberg DM, Goldberg SR (1994) The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. Eur J Pharmacol 271:461-469
84. Shoaib M, Stolerman IP, Kumar RC (1997) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology 113:445-452
85. Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 129:35-43
86. Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402-408
87. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 28:247-259
88. Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, Belcher M, Feyerabend C (1992) Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340: 324-329
89. Sutherland G, Stapleton JA, Russell MAH (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120:418-425
90. Tennant FS Jr, Tarver AL, Rawson RA (1984) Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. NIDA Res Monogr 49: 239-246
91. Tessari M, Valerio E, Chiamulera C, Beardsley PM (1995) Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology 121:282-283
92. Westman EC, Behm FM, Rose JE (1995) Airway sensory replacement combined with nicotine replacement for smoking cessation: a randomized, placebo controlled trial using a citric acid inhaler. Chest 107:1358-1364
93. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
94. Witkin JM (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neurosci Biobehav Rev 18:121-142
95. Zacny JP, Apfelbaum JL, Lichtor JL, Zaragoza JG (1993) Effects of 5-hydroxytryptamine, antagonist, ondansetron, on cigarette smoking, smoke, exposure, and mood in humans. Pharmacol Biochem Behav 44:387-391